Lumify approval leads recent cornea news

The FDA’s approval of Lumify for ocular redness was the most-read recent cornea and external disease news, with international approvals also making headlines.
Here are five of the most-read recent cornea/external disease articles on
1. FDA approves Bausch + Lomb’s Lumify for treatment of eye redness
Lumify is the first over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness. Read more.
2. NovaTears+Omega-3 for evaporative dry eye approved in Europe
The first eye drop to have high concentrations of omega-3 (0.2%)

Full Story →